Type 1 diabetes: Chronic progressive autoimmune disease

Novartis Foundation Symposium

Volumn 292, Issue , 2008, Pages 85-94

  Zhang, Li ^a   Gianani, Roberto ^a   Nakayama, Maki ^a   Liu, Edwin ^a   Kobayashi, Masakazu ^a   Baschal, Erin ^a   Yu, Liping ^a   Babu, Sunanda ^a   Dawson, Abby ^a   Johnson, Kelly ^a   Jahromi, Mohamed ^a   Aly, Theresa ^a   Fain, Pamela ^a   Barker, Jennifer ^a   Rewers, Marian ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HISTOCOMPATIBILITY ANTIGEN; INSULIN;

ANIMAL; AUTOIMMUNITY; CHRONIC DISEASE; CONFERENCE PAPER; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; INSULIN; ISLETS OF LANGERHANS; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED NOD;

EID: 56249094164     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (29)

1. Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ 2006 The haplotype structure of the human major histocompatibility complex. Hum Immunol 67:73-84
2. Aly TA, Eller E, Ide A et al 2006a Multi-SNP Analysis of MHC Region: Remarkable Conservation of HLA-A1-B8-DR3 Haplotype. Diabetes 55:1265-1269
3. Aly TA, Ide A, Jahromi MM et al 2006b Extreme Genetic Risk for Type 1A Diabetes. Proc Natl Acad Sci USA 103:14074-14079
4. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D 1996 Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci USA 93: 2260-2263
5. Barker JM 2006 Type 1 diabetes associated autoimmunity: Natural History, Genetic Associations and Screening. J Clin Endocrinol Metab 91:1210-1217
6. Barker JM, McFann K, Harrison LC et al 2007 Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing. J Pediatr 150:31-36
7. Bingley PJ, Gale EA 2006 Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 49:881-890
8. Eisenbarth GS 1986 Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360-1368
9. Foulis AK, Clark A 1994 Pathology of the pancreas in diabetes mellitus. In: Kahn CR, Weir GC (eds) Joslin's Diabetes Mellitus. Lea & Febiger, Philadelphia, p 265-281
10. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC 2004 Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667
11. Gianani R, Putnam A, Still T et al 2006 Initial results of screening of non-diabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 91:1855-1861
12. Krishnamurthy B, Dudek NL, McKenzie MD et al 2006 Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 116: 3258-3265
13. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC 2005 Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
14. Nakayama M, Abiru N, Moriyama H et al 2005 Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220-223
15. Palmer JP, Fleming GA, Greenbaum CJ et al 2004 C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve beta-Cell Function: Report of an ADA Workshop, 21-22 October 2001. Diabetes 53:250-264
16. Pugliese A 2002 Peripheral antigen-expressing cells and autoimmunity. Endocrinol Metab Clin North Am 31:411-430
17. Redondo MJ, Yu L, Hawa M et al 2001 Heterogenity of type 1 diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354-362
18. Redondo MJ, Babu S, Zeidler A et al 2006 Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol Metab 91:1705-1713
19. Roep BO 2003 The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure. Diabetologia 46:305-321
20. Schlosser M, Koczwara K, Kenk H et al 2005 In insulin-autoantibody- positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 48:1830-1832
21. Shapiro AM, Ricordi C, Hering BJ et al 2006 International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318-1330
22. Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC 2006 Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55: 3238-3245
23. Sosenko JM, Palmer JP, Greenbaum CJ et al 2007 Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 30:38-42
24. Srikanta S, Ganda OP, Jackson RA et al 1983 Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med 99:320-326
25. Stavros D, Gloria A, George WB, Gaetano C, Alberto P 2007 HLA-DR3/4 Heterozygosity is a risk factor for autoantibody conversion and type 1 diabetes recurrenceafter stimulaneous pancreas-kidney transplantation. Clin Immunol 123:s22
26. Stene LC, Barriga K, Hoffman M et al 2006 Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes 7:247-253
27. Todd JA, Walker NM, Cooper JD et al 2007 Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857-864
28. Verge CF, Gianani R, Kawasaki E et al 1996 Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933
29. Wilkin TJ 2006 The accelerator hypothesis: a unifying explanation for type-1 and type-2 diabetes. Nestle Nutr Workshop Ser Clin Perform Programme 11:139-50; discussion 150-3, 139-150